Advertisement
ACADIA Pharmaceuticals Inc.

ACADIA Pharmaceuticals Inc. (ACAD) Stock Overview

Explore ACADIA Pharmaceuticals Inc.’s financial performance, market position, analyst ratings, and future outlook.

ACAD●NASDAQ
HealthcareBiotechnology
$21.72
$0.29(1.35%)
U.S. Market opens in 16h 8m
Advertisement

ACADIA Pharmaceuticals Inc. (ACAD)

Meyka AI Score

Z

Key Financials

Market Cap3.7B
P/E Ratio9.57
EPS (TTM)$2.21
ROE0.36%
Fundamental Analysis

AI Price Forecasts

1 Month$20.38
3 Months$27.07
1 Year Target$27.90

ACAD Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of ACADIA Pharmaceuticals Inc. (ACAD) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 48.79, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $27.90.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 9.57 and a market capitalization of 3.7B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
1.35%
5-Day Change
0.32%
1-Month Change
-2.12%
3-Month Change
-7.14%
6-Month Change
-18.19%
Year-to-Date (YTD) Change
-18.68%
1-Year Change
-0.23%
3-Year Change
-9.39%
5-Year Change
-8.32%
All-Time (Max) Change
224.18%

Contact Information

https://www.acadia-pharm.com
858 558 2871
12830 El Camino Real, San Diego, CA, 92130

Company Facts

653 Employees
IPO DateMay 27, 2004
CountryUS
Actively Trading

Frequently Asked Questions